Literature DB >> 11596984

Naturally occurring mutations in GM2 gangliosidosis: a compendium.

B Triggs-Raine1, D J Mahuran, R A Gravel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11596984     DOI: 10.1016/s0065-2660(01)44081-8

Source DB:  PubMed          Journal:  Adv Genet        ISSN: 0065-2660            Impact factor:   1.944


× No keyword cloud information.
  11 in total

Review 1.  Invertebrate models of lysosomal storage disease: what have we learned so far?

Authors:  Samantha Hindle; Sarita Hebbar; Sean T Sweeney
Journal:  Invert Neurosci       Date:  2011-10-25

2.  Tay-Sachs disease preconception screening in Australia: self-knowledge of being an Ashkenazi Jew predicts carrier state better than does ancestral origin, although there is an increased risk for c.1421 + 1G > C mutation in individuals with South African heritage.

Authors:  Raelia Lew; Leslie Burnett; Anné Proos
Journal:  J Community Genet       Date:  2011-07-15

3.  sp2-Iminosugars targeting human lysosomal β-hexosaminidase as pharmacological chaperone candidates for late-onset Tay-Sachs disease.

Authors:  Manuel González-Cuesta; Irene Herrera-González; M Isabel García-Moreno; Roger A Ashmus; David J Vocadlo; José M García Fernández; Eiji Nanba; Katsumi Higaki; Carmen Ortiz Mellet
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

4.  Gangliosides and Cell Surface Ganglioside Metabolic Enzymes in the Nervous System.

Authors:  Massimo Aureli; Laura Mauri; Emma Veronica Carsana; Dorina Dobi; Silvia Breviario; Giulia Lunghi; Sandro Sonnino
Journal:  Adv Neurobiol       Date:  2023

Review 5.  The glycosphingolipid hydrolases in the central nervous system.

Authors:  Massimo Aureli; Maura Samarani; Nicoletta Loberto; Rosaria Bassi; Valentina Murdica; Simona Prioni; Alessandro Prinetti; Sandro Sonnino
Journal:  Mol Neurobiol       Date:  2013-11-27       Impact factor: 5.590

6.  Elevation of Global O-GlcNAc in rodents using a selective O-GlcNAcase inhibitor does not cause insulin resistance or perturb glucohomeostasis.

Authors:  Matthew S Macauley; Xiaoyang Shan; Scott A Yuzwa; Tracey M Gloster; David J Vocadlo
Journal:  Chem Biol       Date:  2010-09-24

7.  Linear-after-the-exponential (LATE)-PCR: an advanced method of asymmetric PCR and its uses in quantitative real-time analysis.

Authors:  J Aquiles Sanchez; Kenneth E Pierce; John E Rice; Lawrence J Wangh
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

Review 8.  Genetics and Therapies for GM2 Gangliosidosis.

Authors:  Maria Begona Cachon-Gonzalez; Eva Zaccariotto; Timothy Martin Cox
Journal:  Curr Gene Ther       Date:  2018       Impact factor: 4.391

9.  Neuraminidase-1 contributes significantly to the degradation of neuronal B-series gangliosides but not to the bypass of the catabolic block in Tay-Sachs mouse models.

Authors:  Z K Timur; S Akyildiz Demir; C Marsching; R Sandhoff; V Seyrantepe
Journal:  Mol Genet Metab Rep       Date:  2015-08-15

10.  Tay-Sachs disease mutations in HEXA target the α chain of hexosaminidase A to endoplasmic reticulum-associated degradation.

Authors:  Devin Dersh; Yuichiro Iwamoto; Yair Argon
Journal:  Mol Biol Cell       Date:  2016-09-28       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.